Abstract
Tedisamil is a new bradycardic agent with an inhibitory action on K+ channels in cardiac muscle, and secondary beneficial effects in experimentally induced cardiac ischemia. In whole-cell clamp studies in enzymatically dispersed, single smooth muscle cells from the guinea-pig portal vein, tedisamil inhibited the delayed rectifier K+ current (determined as the charge transferred through the cell membrane), the mean concentration for half-maximal inhibition being 2.9 μM. In contrast to controls in the absence of drugs or in the presence of the classical K+ channel blockers barium, tetraethylammonium or 4-aminopyridine, the time course of the delayed rectifier K+ current in the presence of tedisamil could no longer be fitted by a single exponential, and signs of an accelerated inactivation by tedisamil were obtained. The slow onset of the response to tedisamil applied to the outside of the vascular myocytes, and the finding that tedisamil applied directly to the cytosol via the pipette was highly effective, suggest an intracellular site of action.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Beatch GN, Abraham S, MacLeod BA, Yoshida NR, Walker MJA (1991) Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker. Br J Pharmacol 102:13–18
Bray K, Quast U (1991) Tedisamil (KC8857) differentially inhibits the 86Rb+ efflux-stimulating and vasorelaxant properties of cromakalim. Eur J Pharmacol 200:163–165
Dukes ID, Morad M (1989) Tedisamil inactivates transient outward K+ current in rat ventricular myocytes. Am J Physiol 257:H1746-H1749
Dukes ID, Cleeman L, Morad M (1990) Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells. J Pharmacol Exp Ther 254:560–569
Grohs JG, Fischer G, Raberger G (1989) Cardiac and hemodynamic effects of the selective bradycardic agent KC 8857 during exercise-induced myocardial ischemia. Eur J Pharmacol 161:53–60
Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391:855–100
Kreye VAW, Pfründer D, Theiss U (1991) Tedisamil blocks 86Rb efflux and single K+ channel currents in vascular smooth muscle. Naunyn-Schmiedeberg's Arch 343 [Suppl]:R63
Kreye VAW, Pfründer D, Theiss U (1992) Effects of the K+ channel blocker tedisamil on 86Rb efflux induced by cromakalim, high potassium and noradrenaline, and on mechanical tension in rabbit isolated vascular smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 345:238–243
Kühl UG, Buschmann G (1987) Cardiovascular profile of KC8857 in comparison with other cardioactive agents. J Mol Cell Cardiol 19 [Suppl III]:50
Maruyama I, Yoshida C, Kobayashi M, Oyamada H, Momose K (1987) Preparation of single smooth muscle cells from guinea pig taenia coli by combinations of purified collagenase and papain. J Pharmacol Methods 18:151–161
Noack T, Deitmer P, Golenhofen K (1990) Features of a calcium independent, caffeine sensitive outward current in single smooth muscle cells from guinea pig portal vein. Pflügers Arch 416:467–469
Pfründer D, Kreye VAW (1991) Tedisamil blocks single large-conductance Ca2+-activated K+ channels in membrane patches from smooth muscle cells of the guinea-pig portal vein. Pflügers Arch 418:308–312
Pfründer D, Kreye VAW (1991) Tedisamil blocks different K+ channels in isolated vascular smooth muscle. Pflügers Arch 418 [Suppl 1]:R49
Rudy B (1988) Diversity and ubiquity of K channels. Neuroscience 25:729–749
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pfründer, D., Kreye, V.A.W. Tedisamil inhibits the delayed rectifier K+ current in single smooth muscle cells of the guinea-pig portal vein. Pflügers Arch 421, 22–25 (1992). https://doi.org/10.1007/BF00374728
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00374728